bluebird bio Stock News

Source: rafapress / Shutterstock Bluebird Bio (NASDAQ: BLUE ) stock is on the move Thursday following U.S. Food and Drug Administration (FDA) approval for ZYNTEGLO. ZYNTEGLO is a gene therapy designed

bluebird's (BLUE) Zynteglo gets FDA-approval for transfusion-dependent beta-thalassemia in adult and pediatric patients. The stock gains.

Shares of Buebird Bio Inc. BLUE, +7.90% jumped 12.1% in trading on Wednesday after the Food and Drug Administration approved the company's gene therapy as a treatment for beta‑thalassemia in some ad

bluebird bio's (BLUE) efforts to develop its gene-therapy pipeline are impressive. The FDA is reviewing BLUE's filing for beti-cel as a treatment for beta thalassemia and eli-cel for cerebral adrenole

Investing in biotech stocks without any drugs on the market can be scary. These suggestions can help you make money in this high-risk sector.

While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

bluebird (BLUE) posts a narrower-than-expected loss in the second quarter. However, sales miss estimates.

Bluebird (BLUE) delivered earnings and revenue surprises of 1.53% and 76.50%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

These high-tech biotech stocks made a sharp U-turn this week after a rough start to the year.

Investors are on the hunt for oversold stocks with bargain valuations that could jump in value once optimism returns to the stock market. The post 7 Oversold Stocks to Buy in July 2022 appeared first

Bluebird (BLUE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

There's probably a short squeeze in progress.

Bristol Myers Squibb and Bluebird Bio have drugs in their pipelines that could soon earn FDA approval.

The company may be about to turn things around.

The company may be about to turn things around.